The Study on the Pulmonary Vessel Disease and Its Its Changes in Metabolism of Small Molecules

Beijing Chao Yang Hospital1 site in 1 country18 target enrollmentAugust 2014

ConditionsPulmonary Vessel Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Pulmonary Vessel Disease
Sponsor: Beijing Chao Yang Hospital
Enrollment: 18
Locations: 1
Primary Endpoint: The changes of patients'metabolism of small molecules
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to investigate the changes of the pulmonary vessel disease and its metabolism of small molecules.

Detailed Description

The patient with acute respiratory distress syndrome and sepsis come to hospital ,the investigators will blood them to study the changes in metabolism of small molecules.

Registry

clinicaltrials.gov

Start Date

August 2014

End Date

August 2016

Last Updated

10 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Beijing Chao Yang Hospital

Responsible Party

Principal Investigator

Yingmin Ma

Vice president of the Beijing chaoyang hospital

Beijing Chao Yang Hospital

Eligibility Criteria

Inclusion Criteria

•the aged between 18 and 85;Patients with ARDS and sepsis;Patients with only sepsis;normal

Exclusion Criteria

•Age \<18 or \>85, pregnancy, diabetes mellitus, cardiac pulmonary edema, can lead to other conditions of ARDS: severe trauma, a large number of blood transfusions, severe acute pancreatitis, etc., end-stage tumor.